At Innova Medical Group, we believe better healthcare outcomes around the globe are within reach – and it starts with scalable and cost-effective screening and diagnostic options.

The global pandemic opened up a new era of virtual care and illustrated the need for better testing solutions beyond COVID-19.

We quickly became the world’s largest provider of COVID-19 tests, and we are determined to execute on this model across infectious disease, other chronic conditions and wellness, thereby empowering the global population to take control of their own care procurement and health decisions.

Our goal is to play an integral role in care pathways by vitally contributing to improving patient outcomes and ultimately cutting overall treatment costs and bettering lives.

Here is how we do it:

Innovation

Forward-thinking innovation and a passion for cutting-edge, life-enhancing technology backed by world-leading science is at the heart of everything we do. With a panoramic vision spanning the present to the future, we are progressive and always striving to be better.

Agility

Our ability to act quickly and decisively means we can deliver nimble, scalable solutions rapidly and efficiently. We have developed the infrastructure to meet the demands of our mission.

Reliability

Our strategic and iterative approach enables us to create, build and deploy quality, trusted solutions that are both intuitive and secure to use. The extensive experience of our people and our proven track record during the COVID-19 pandemic cement our status as a credible and dependable healthcare solutions provider.

Innova Medical Group is a wholly owned subsidiary of Pasaca Capital, Inc. and is headquartered in Pasadena, CA.